Conor Steuer

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

Medicine, Oncology, Metastasis +9

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy

Mehmet Asım Bilen, Dylan J. Martini, Yuan Liu et al. · Cancer · 2018 · 161 citations · Full text

Medicine, Immunology, Oncology +16

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Mehmet Asım Bilen, Julie M. Shabto, Dylan J. Martini et al. · BMC Cancer · 2019 · 125 citations · Full text

Medicine, Immunology, Oncology +17

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

Douglas R. Adkins, Jessica Ley, Prakash Neupane et al. · The Lancet Oncology · 2019 · 124 citations

Medicine, Oncology, Pharmacology +8

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium

Conor Steuer, Madhusmita Behera, Lynne D. Berry et al. · Cancer · 2015 · 115 citations · Full text

Medicine, Genetics, Oncology +17